Alzecure Pharma Q1’21: Our Comment

Ask me later

Ask me later

How likely are you to recommend Redeye to a friend or colleague?

1

2

3

4

5

6

7

8

9

10

Not likely

Very likely

Not likely

1

2

3

4

5

6

7

8

9

10

Very likely

Message received

Thanks again for rating us!

Alzecure Pharma Q1’21: Our Comment

2021-05-05

14:10

AH

Anders Hedlund

AlzeCure Pharma

4.43

▲ 0.07

1.61%

Premium Plan required to unlock

Redeye gives its first impression on Alzecure’s Q1’21 report. Overall, the burn-rate was very much as expected

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

AlzeCure Pharma

4.43

▲ 0.07

1.61%

Premium Plan required to unlock